WL Issued to Amrex Zetron Inc FDA Tue, 14 Apr 2009 00:00:00 -0400 FDA Warning Letter Issued to Amrex Zetron Inc on 14 Apr 2009 by Los Angeles District Office WL Issued to Coast Institutional Review Board FDA Tue, 14 Apr 2009 00:00:00 -0400 FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research WL Issued to Branitz, Bruce, MD FDA Thu, 09 Apr 2009 00:00:00 -0400 FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research WL Issued to Cote, Charles J., MD FDA Mon, 02 Mar 2009 00:00:00 -0400 FDA Warning Letter Issued to Cote, Charles J., MD on 02 Mar 2009 by Center for Drug Evaluation and Research WL Issued to Genzyme Corporation FDA Fri, 27 Feb 2009 00:00:00 -0400 FDA Warning Letter Issued to Genzyme Corporation on 27 Feb 2009 by New England District Office WL Issued to Hammill Manufacturing Company FDA Tue, 06 Jan 2009 00:00:00 -0400 FDA Warning Letter Issued to Hammill Manufacturing Company on 06 Jan 2009 by Cincinnati District Office
CFDA: FDA Latest Drug GCP Warning Letters
WL Issued to Coast Institutional Review Board FDA Tue, 14 Apr 2009 00:00:00 -0400 FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research WL Issued to Branitz, Bruce, MD FDA Thu, 09 Apr 2009 00:00:00 -0400 FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research WL Issued to Bukowski, Ronald M, MD FDA Mon, 30 Mar 2009 00:00:00 -0400 FDA Warning Letter Issued to Bukowski, Ronald M, MD on 30 Mar 2009 by Center for Drug Evaluation and Research WL Issued to Youabian, Inc FDA Tue, 17 Mar 2009 00:00:00 -0400 FDA Warning Letter Issued to Youabian, Inc on 17 Mar 2009 by Los Angeles District Office WL Issued to Provena St. Joseph's Medical Center IRB FDA Thu, 12 Mar 2009 00:00:00 -0400 FDA Warning Letter Issued to Provena St. Joseph's Medical Center IRB on 12 Mar 2009 by Center for Biologics Evaluation and Research WL Issued to Paulson, Daniel M., MD FDA Wed, 11 Mar 2009 00:00:00 -0400 FDA Warning Letter Issued to Paulson, Daniel M., MD on 11 Mar 2009 by Center for Drug Evaluation and Research
Eskalith - Fact sheet about this brand of lithium carbonate. Includes dosage, side effects, drug and food interaction, and images of the pills and capsules.
Meta Description: [ Eskalith is used to treat the manic episodes of manic-depressive illness, a condition in which a person's mood swings from depression to excessive excitement. ]
Lithium - Information from DrugDigest on dosage, usage, side effects, and interactions.
Lithium Carbonate - Information sheet covers description, pharmacology, uses, dosage, side effects, and other advice for patients.
Meta Description: [ Lithium - an antipsychotic, antimanic medication for those with Bipolar Disorder, Mania; treatment of manic episodes. Uses, dosage, side effects. ]
Lithium Carbonate - Internet Mental Health discussion covers pharmacology, indications and contraindications, precautions, dosage, and other topics. From a Canadian monograph.
Lithium: Eskalith, Lithobid, Lithonate - Public Citizen's eLetter advice sheet for patients, including adverse effects, drug interactions, and periodic medical tests for people using this medication.
404Virtual Hospital: Lithium Adverse Effects - Review of non-renal adverse effects that occur at therapeutic levels, written for medical professionals.
Meta Description: [ Virtual Hospital was a digital library of health information in pediatrics, paediatrics, and radiology for pediatric education and radiology education ]